For research use only. NOT for use in diagnostic procedures.
This application note describes the extraction of a panel of steroid hormones from human serum using ISOLUTE® SLE+ Supported Liquid Extraction plates prior to LC/MS-MS analysis. The simple sample preparation procedure delivers clean extracts and high, reproducible recoveries (>75%, RSD <10% ) for all analytes in human serum, with linearity >0.99 in the range 5–5000 pg/mL.
ISOLUTE SLE+ Supported Liquid Extraction plates offer an efficient alternative to traditional liquid-liquid extraction (LLE) for bioanalytical sample preparation, providing high analyte recoveries, no emulsion formation, and significantly reduced sample preparation.
Cortisol, 18-OH-Corticosterone, 21-Deoxycortisol, Cortisone, Estradiol, 17-OH-Pregnenolone, Aldosterone, 11-Deoxycortisol, Corticosterone, Estrone, DHEA, 17-OH-Progesterone, DHEAS, Testosterone, Dihydrotestosterone (DHT), Pregnenolone, Androstenedione, 11-deoxycorticosterone, Progesterone
DHT-d3 and Aldosterone-d4
ISOLUTE® SLE+ 400 µL Supported Liquid Extraction plate, part number 820-0400-P01.
Add 25 µL of methanolic ISTD to human serum (total conc. 250 pg/mL). Mix.
Apply 300 µL of sample into each well of the ISOLUTE SLE+ plate. Using a Biotage® PRESSURE+96 Positive Pressure Manifold, apply 2–5 psi of pressure to load samples onto the sorbent. Wait 5 minutes for the sample to equilibrate on the sorbent.
Apply ethyl acetate (500 µL) and allow to flow under gravity for 5 minutes. Apply a further aliquot of ethyl acetate (500 µL) and allow to flow for 5 minutes under gravity. Apply pressure (5–10 seconds) to remove any remaining extraction solvent.
*this elution procedure should be used when the polar metabolite DHEAS is included in the steroid panel. If DHEAS is not required, and alternative elution solvent system (ethyl acetate: hexane, 75:25, v/v, 2 x 500 µL) should be used. See results section.
Dry the extract in a stream of air or nitrogen using a Biotage® SPE Dry at 40 °C, 20 to 40 L/min, for 20 minutes. Reconstitute evaporated samples with 200 µL of 50:50 (v/v) mobile phase A: mobile phase B, and mix thoroughly.
Shimadzu Nexera UHPLC
ACE C18 (100 mm x 2.1 mm, 1.7 µm)
A: 0.2 mM Ammonium Fluoride (aq)
B: Methanol
0.4 mL min
40 oC
10 µL
Table 1. UHPLC gradient
|
Time (min) |
%A |
%B |
|
0 |
50 |
50 |
|
3 |
40 |
60 |
|
8 |
10 |
90 |
|
9 |
5 |
95 |
|
9.1 |
5 |
95 |
|
9.5 |
50 |
50 |
Shimadzu 8060 Triple Quadrupole MS using ES interface
3 L/min
3 L/min
17 L/min
400 oC
250 oC
400 oC
270 kPa
Table 2. MS conditions and retention times for target analytes in positive and negative mode.
|
Analytes |
MRM Transition |
Collision Energy |
Ion Mode |
|
DHEAS |
367.1 > 97.05 |
33 |
- |
|
Cortisol |
363.4 > 121.25 |
-24 |
+ |
|
18-OH-Corticosterone |
363.3 > 269.2 |
-16 |
+ |
|
Cortisone |
361.3 > 163.15 |
-22 |
+ |
|
21-Deoxycortisol |
347.1 > 311.2 |
-16 |
+ |
|
Estradiol |
271.1 > 145.2 |
39 |
- |
|
Aldosterone d4 |
363.1 > 190.3 |
19 |
- |
|
Aldosterone |
359.1 > 189.25 |
18 |
- |
|
17-OH-Pregnenolone |
315.3 > 297.2 |
-13 |
+ |
|
11-Deoxycortisol |
347.3 > 109.25 |
-27 |
+ |
|
Corticosterone |
347.3 > 329.25 |
-16 |
+ |
|
Estrone |
269.2 > 145.2 |
37 |
- |
|
11-Deoxycorticosterone |
331.3 > 109.05 |
-25 |
+ |
|
DHEA |
289.3 > 253.2 |
-13 |
+ |
|
Testosterone |
289.3 > 97.05 |
-23 |
+ |
|
DHT-d3 |
294.4 > 258.25 |
-16 |
+ |
|
DHT |
291.3 > 255.25 |
-15 |
+ |
|
Androstenedione |
287.3 > 97.2 |
-21 |
+ |
|
Pregnenolone |
299.3 > 159.25 |
-20 |
+ |
|
17-OH-Progesterone |
331.3 > 97.1 |
-22 |
+ |
|
Progesterone |
315.2 > 97.2 |
-22 |
+ |
If the polar metabolite DHEAS is to be included in the steroid suite, ethyl acetate should be used as the elution solvent. If DHEAS is not required, an alternative elution solvent, ethyl acetate: hexane (75:25, v/v) can be used. Recovery data for both elution solvent systems is shown below.
The optimized ISOLUTE® SLE+ protocol using ethyl acetate demonstrated analyte recoveries greater than 75% as shown in Figure 2. The optimized ISOLUTE SLE+ protocol using ethyl acetate:hexane (75:25, v/v) demonstrated analyte recoveries greater than 80% (except DHEAS) as shown in Figure 3. RSDs were below 10% for all analytes using both protocols.
Removal of phospholipids was demonstrated by monitoring MRM transitions using the common product ion at m/z 184. Figure 3. Shows the serum phospholipid profile comparing lysophospholipids (bottom trace) and larger molecular weight phospholipids (top trace) extracted using the optimized ISOLUTE SLE+ protocols and 100 µL of serum protein precipitated with 400 µL of acetonitrile. Both elution solvents (EtOAc and EtOAc/Hexane(75/25, v/v) eliminated phospholipids compared to a protein precipitated sample.
Figure 3. Phospholipid profile comparison between protein precipitated serum and optimized ISOLUTE SLE+ extracts using EtOAc or EtOAc/Hexane (75/25, v/v) as elution solvents.
Figure 4 shows representative chromatography obtained from stripped serum spiked at 5 ng/mL. Satisfactory resolution of the various isobars was obtained using the ACE C18 UPLC column. In order to achieve low level detection of analytes in positive and negative ion modes a combination of 0.2 mM NH4F (aq) and MeOH was utilized.
Linearity was investigated using stripped serum spiked between 5–5000 pg/mL. Good linearity was observed for all analytes typically delivering r2 values greater than 0.99. Table 3. details linearity performance and associated LOQ for each analyte using EtOAc and EtOAc/Hexane (75/25, v/v) as elution solvents. Selected calibration curves using EtOAc as elution solvent are shown in Figure 5.
Table 3. Analyte calibration curve r2 and LOQ performance.
|
Analytes |
r2 EtOAc |
LLOQ (pgmL) EtOAc |
r2 EtOAc/Hexane 75/25 (v/v) |
LLOQ (pg/mL) EtOAc/ Hexane 75/25 (v/v) |
|
DHEAS |
0.991 |
<1000 |
- |
|
|
Cortisol |
0.998 |
< 10 |
0.998 |
< 10 |
|
18-OH-Corticosterone |
0.996 |
< 100 |
0.997 |
< 100 |
|
Cortisone |
0.992 |
< 5 |
0.994 |
< 5 |
|
21-Deoxycortisol |
0.997 |
25 |
0.998 |
25 |
|
Estradiol |
0.996 |
< 25 |
0.997 |
< 25 |
|
Aldosterone |
0.998 |
25 |
0.999 |
25 |
|
17-OH-Pregnenolone |
0.999 |
< 500 |
0.999 |
< 500 |
|
11-Deoxycortisol |
0.999 |
5 |
0.998 |
5 |
|
Corticosterone |
0.997 |
< 50 |
0.999 |
< 50 |
|
Estrone |
0.997 |
10 |
0.999 |
10 |
|
11-Deoxycorticosterone |
0.998 |
< 10 |
0.999 |
< 10 |
|
DHEA |
0.994 |
< 1000 |
0.994 |
< 1000 |
|
Testosterone |
0.994 |
< 5 |
0.998 |
< 5 |
|
DHT |
0.994 |
< 250 |
0.999 |
< 250 |
|
Androstenedione |
0.990 |
10 |
0.998 |
< 10 |
|
Pregnenolone |
0.991 |
< 250 |
0.998 |
< 250 |
|
17-OH-Progesterone |
0.994 |
< 10 |
0.998 |
< 10 |
|
Progesterone |
0.993 |
< 5 |
0.999 |
< 5 |
Figure 5. Calibration curves for Estradiol (a), Testosterone (b), 17-OH-Progesterone (c) and Androstenedione (d).
|
Part Number |
Description |
Quantity |
|
820-0400-P01 |
ISOLUTE SLE+ 400 µL Supported Liquid Extraction Plate |
1 |
|
120-5203 |
Collection plate, 2 mL square |
50 |
|
PPM-96 |
Biotage® PRESSURE+ 96 Positive Pressure Manifold |
1 |
|
SD-9600-DHS-EU |
Biotage® SPE Dry 96 Sample Evaporator 220/240 V |
1 |
|
SD-9600-DHS-NA |
Biotage® SPE Dry 96 Sample Evaporator 100/120 V |
1 |
Literature Number: AN890